• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

循环短链脂肪酸与 2 型糖尿病患者非酒精性脂肪性肝病严重程度的关系。

Circulating Short-Chain Fatty Acids and Non-Alcoholic Fatty Liver Disease Severity in Patients with Type 2 Diabetes Mellitus.

机构信息

Department of Family Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University, Kaohsiung 801, Taiwan.

Department of Family Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 807, Taiwan.

出版信息

Nutrients. 2023 Mar 31;15(7):1712. doi: 10.3390/nu15071712.

DOI:10.3390/nu15071712
PMID:37049552
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10097193/
Abstract

(1) Background: Non-alcoholic fatty liver disease (NAFLD) is a major global health concern. The increasing prevalence of NAFLD has been related to type 2 diabetes mellitus (T2D). However, the relationship between short-chain fatty acids (SCFAs) and NAFLD severity is ambiguous in T2D subjects. This study aimed to explore the association of SCFAs with the severity of NAFLD in T2D patients. (2) Methods: We employed echography to examine the severity of hepatic steatosis. The serum levels of nine SCFAs, namely, formate, acetate, propionate, butyrate, isobutyrate, methylbutyrate, valerate, isovalerate, and methylvalerate, were measured using gas chromatography mass spectrometry. (3) Results: A total of 259 T2D patients was enrolled in this cross-sectional study. Of these participants, 117 with moderate to severe NAFLD had lower levels of formate, isobutyrate, and methylbutyrate than the 142 without NAFLD or with mild NAFLD. Lower circulating levels of isobutyrate and methylbutyrate were associated with an increased severity of NAFLD. A relationship between NAFLD severity and circulating isobutyrate and methylbutyrate levels was found independently of a glycated hemoglobin (HbA1C) level of 7.0%. (4) Conclusion: Circulating levels of isobutyrate and methylbutyrate were significantly and negatively correlated with NAFLD severity in the enrolled T2D patients. SCFAs may be related to NAFLD severity in T2D patients.

摘要

(1) 背景:非酒精性脂肪性肝病(NAFLD)是一个全球性的主要健康问题。NAFLD 的患病率不断增加与 2 型糖尿病(T2D)有关。然而,在 T2D 患者中,短链脂肪酸(SCFAs)与 NAFLD 严重程度的关系尚不清楚。本研究旨在探讨 SCFAs 与 T2D 患者 NAFLD 严重程度的关系。

(2) 方法:我们采用超声检查评估肝脂肪变性的严重程度。采用气相色谱质谱法检测血清中 9 种 SCFAs(甲酸、乙酸、丙酸、丁酸、异丁酸、甲基丁酸、戊酸、异戊酸和甲基戊酸)的水平。

(3) 结果:这项横断面研究共纳入 259 例 T2D 患者。其中 117 例中重度 NAFLD 患者的甲酸、异丁酸和甲基丁酸水平低于无 NAFLD 或轻度 NAFLD 的 142 例患者。循环中异丁酸和甲基丁酸水平较低与 NAFLD 严重程度增加相关。NAFLD 严重程度与循环中异丁酸和甲基丁酸水平之间的关系独立于糖化血红蛋白(HbA1C)水平为 7.0%。

(4) 结论:在纳入的 T2D 患者中,循环异丁酸和甲基丁酸水平与 NAFLD 严重程度呈显著负相关。SCFAs 可能与 T2D 患者的 NAFLD 严重程度有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58e7/10097193/6b13a1963f09/nutrients-15-01712-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58e7/10097193/8cdf5e8646ec/nutrients-15-01712-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58e7/10097193/6b13a1963f09/nutrients-15-01712-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58e7/10097193/8cdf5e8646ec/nutrients-15-01712-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58e7/10097193/6b13a1963f09/nutrients-15-01712-g002.jpg

相似文献

1
Circulating Short-Chain Fatty Acids and Non-Alcoholic Fatty Liver Disease Severity in Patients with Type 2 Diabetes Mellitus.循环短链脂肪酸与 2 型糖尿病患者非酒精性脂肪性肝病严重程度的关系。
Nutrients. 2023 Mar 31;15(7):1712. doi: 10.3390/nu15071712.
2
Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.用于非酒精性脂肪性肝病和非酒精性脂肪性肝炎的他汀类药物。
Cochrane Database Syst Rev. 2013 Dec 27;2013(12):CD008623. doi: 10.1002/14651858.CD008623.pub2.
3
Correlation of Short Chain Fatty Acid (SCFA) Levels with Transient Elastography Values and Controlled Attenuation Parameters in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD).非酒精性脂肪性肝病(NAFLD)患者短链脂肪酸(SCFA)水平与瞬时弹性成像值及受控衰减参数的相关性
Acta Med Indones. 2025 Apr;57(2):167-174.
4
Prevalence of nonalcoholic fatty liver disease and liver cirrhosis in Chinese adults with type 2 diabetes mellitus.中国 2 型糖尿病患者中非酒精性脂肪性肝病和肝硬化的患病率。
J Diabetes. 2024 May;16(5):e13564. doi: 10.1111/1753-0407.13564.
5
Association of serum lactate dehydrogenase levels with non-alcoholic fatty liver disease and advanced hepatic fibrosis in the United States: a cross-sectional study using NHANES data from 2007 to 2018.美国血清乳酸脱氢酶水平与非酒精性脂肪性肝病及晚期肝纤维化的关联:一项利用2007年至2018年美国国家健康与营养检查调查(NHANES)数据的横断面研究
BMC Gastroenterol. 2025 Jul 1;25(1):467. doi: 10.1186/s12876-025-04057-w.
6
Nutritional supplementation for nonalcohol-related fatty liver disease: a network meta-analysis.非酒精性脂肪性肝病的营养补充:一项网状Meta分析。
Cochrane Database Syst Rev. 2021 Jul 19;7(7):CD013157. doi: 10.1002/14651858.CD013157.pub2.
7
Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.胰岛素增敏剂治疗非酒精性脂肪性肝病:系统评价。
Health Technol Assess. 2011 Nov;15(38):1-110. doi: 10.3310/hta15380.
8
Vitamin E for people with non-alcoholic fatty liver disease.维生素 E 治疗非酒精性脂肪性肝病。
Cochrane Database Syst Rev. 2024 Oct 16;10(10):CD015033. doi: 10.1002/14651858.CD015033.pub2.
9
Pharmacological interventions for non-alcohol related fatty liver disease (NAFLD): an attempted network meta-analysis.非酒精性脂肪性肝病(NAFLD)的药物干预:一项网状Meta分析尝试
Cochrane Database Syst Rev. 2017 Mar 30;3(3):CD011640. doi: 10.1002/14651858.CD011640.pub2.
10
The Prevalence of Small Intestinal Bacterial Overgrowth in Patients with Non-Alcoholic Liver Diseases: NAFLD, NASH, Fibrosis, Cirrhosis-A Systematic Review, Meta-Analysis and Meta-Regression.非酒精性肝病患者小肠细菌过度生长的患病率:NAFLD、NASH、纤维化、肝硬化-系统评价、荟萃分析和荟萃回归。
Nutrients. 2022 Dec 9;14(24):5261. doi: 10.3390/nu14245261.

引用本文的文献

1
Impact of a high dietary fiber cereal meal intervention on the progression of liver fibrosis in T2DM with MASLD.高膳食纤维谷物餐干预对伴有代谢功能障碍相关脂肪性肝病的2型糖尿病患者肝纤维化进展的影响
Front Endocrinol (Lausanne). 2025 Sep 1;16:1623136. doi: 10.3389/fendo.2025.1623136. eCollection 2025.
2
Circulating short chain fatty acid levels and body composition in type 2 diabetes mellitus.2型糖尿病患者的循环短链脂肪酸水平与身体组成
Int J Med Sci. 2025 Apr 22;22(10):2289-2297. doi: 10.7150/ijms.111920. eCollection 2025.
3
The Role of Short-Chain Fatty Acids in Metabolic Dysfunction-Associated Steatotic Liver Disease and Other Metabolic Diseases.

本文引用的文献

1
Corrigendum to 'EASL recommendations on treatment of hepatitis C: Final update of the series [J Hepatol 73 (2020) 1170-1218].《欧洲肝脏研究学会丙型肝炎治疗推荐:系列最终更新版》勘误 [《肝脏病学杂志》73卷(2020年)1170 - 1218页]
J Hepatol. 2023 Feb;78(2):452. doi: 10.1016/j.jhep.2022.10.006. Epub 2022 Dec 1.
2
A highly sensitive, simple, and fast gas chromatography-mass spectrometry method for the quantification of serum short-chain fatty acids and their potential features in central obesity.一种用于定量检测血清中短链脂肪酸及其在中心性肥胖中潜在特征的高灵敏度、简单、快速的气相色谱-质谱法。
Anal Bioanal Chem. 2021 Nov;413(27):6837-6844. doi: 10.1007/s00216-021-03639-3. Epub 2021 Sep 17.
3
短链脂肪酸在代谢功能障碍相关脂肪性肝病及其他代谢性疾病中的作用
Biomolecules. 2025 Mar 22;15(4):469. doi: 10.3390/biom15040469.
4
sp. for the Attenuation of Metabolic Dysfunction-Associated Steatotic Liver Disease in Mice.用于减轻小鼠代谢功能障碍相关脂肪性肝病的物种。
Microorganisms. 2024 Dec 3;12(12):2488. doi: 10.3390/microorganisms12122488.
5
Models incorporating physical, laboratory and gut metabolite markers can be used to predict severe hepatic steatosis in MAFLD patients.纳入身体、实验室和肠道代谢物标志物的模型可用于预测MAFLD患者的严重肝脂肪变性。
Kaohsiung J Med Sci. 2024 Dec;40(12):1095-1105. doi: 10.1002/kjm2.12904. Epub 2024 Nov 4.
6
Beneficial Effects of the Ketogenic Diet on Nonalcoholic Fatty Liver Disease (NAFLD/MAFLD).生酮饮食对非酒精性脂肪性肝病(NAFLD/MAFLD)的有益作用。
J Clin Med. 2024 Aug 17;13(16):4857. doi: 10.3390/jcm13164857.
7
Short-Chain Fatty Acids and Human Health: From Metabolic Pathways to Current Therapeutic Implications.短链脂肪酸与人类健康:从代谢途径到当前的治疗意义
Life (Basel). 2024 Apr 26;14(5):559. doi: 10.3390/life14050559.
8
Probiotic Mixture Ameliorates a Diet-Induced MASLD/MASH Murine Model through the Regulation of Hepatic Lipid Metabolism and the Gut Microbiome.益生菌混合物通过调节肝脂代谢和肠道微生物群改善饮食诱导的 MASLD/MASH 小鼠模型。
J Agric Food Chem. 2024 Apr 17;72(15):8536-8549. doi: 10.1021/acs.jafc.3c08910. Epub 2024 Apr 4.
9
Could Adverse Effects of Antibiotics Due to Their Use/Misuse Be Linked to Some Mechanisms Related to Nonalcoholic Fatty Liver Disease?抗生素的使用/滥用所产生的不良反应是否与非酒精性脂肪性肝病的某些机制有关?
Int J Mol Sci. 2024 Feb 6;25(4):1993. doi: 10.3390/ijms25041993.
10
What are the common downstream molecular events between alcoholic and nonalcoholic fatty liver?酒精性和非酒精性脂肪肝的下游常见分子事件有哪些?
Lipids Health Dis. 2024 Feb 8;23(1):41. doi: 10.1186/s12944-024-02031-1.
Faecal microbial metabolites of proteolytic and saccharolytic fermentation in relation to degree of insulin resistance in adult individuals.
与成人胰岛素抵抗程度相关的蛋白水解和糖解发酵的粪便微生物代谢产物。
Benef Microbes. 2021 Jun 15;12(3):259-266. doi: 10.3920/BM2020.0179. Epub 2021 Apr 21.
4
Short chain fatty acids in human gut and metabolic health.肠道内的短链脂肪酸与代谢健康。
Benef Microbes. 2020 Sep 1;11(5):411-455. doi: 10.3920/BM2020.0057. Epub 2020 Aug 31.
5
Gut Microbiota Metabolites in NAFLD Pathogenesis and Therapeutic Implications.非酒精性脂肪性肝病发病机制中的肠道微生物群代谢产物及治疗意义。
Int J Mol Sci. 2020 Jul 23;21(15):5214. doi: 10.3390/ijms21155214.
6
Combined Amelioration of Prebiotic Resveratrol and Probiotic on Obesity and Nonalcoholic Fatty Liver Disease.联合应用益生元白藜芦醇和益生菌改善肥胖和非酒精性脂肪性肝病。
Nutr Cancer. 2021;73(4):652-661. doi: 10.1080/01635581.2020.1767166. Epub 2020 May 21.
7
Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders.肠道微生物群与人类非酒精性脂肪性肝病:从代谢紊乱中解析微生物特征。
Nat Rev Gastroenterol Hepatol. 2020 May;17(5):279-297. doi: 10.1038/s41575-020-0269-9. Epub 2020 Mar 9.
8
Hepatitis B-related outcomes following direct-acting antiviral therapy in Taiwanese patients with chronic HBV/HCV co-infection.台湾地区慢性 HBV/HCV 合并感染患者接受直接作用抗病毒治疗后的乙型肝炎相关结局。
J Hepatol. 2020 Jul;73(1):62-71. doi: 10.1016/j.jhep.2020.01.027. Epub 2020 Feb 14.
9
The Effect of One Anastomosis Gastric Bypass on Branched-Chain Fatty Acid and Branched-Chain Amino Acid Metabolism in Subjects with Morbid Obesity.肥胖患者单吻合口胃旁路手术对支链脂肪酸和支链氨基酸代谢的影响。
Obes Surg. 2020 Jan;30(1):304-312. doi: 10.1007/s11695-019-04157-z.
10
Circulating microbiota-derived metabolites: a "liquid biopsy?循环微生物衍生代谢物:一种“液体活检”?
Int J Obes (Lond). 2020 Apr;44(4):875-885. doi: 10.1038/s41366-019-0430-0. Epub 2019 Aug 6.